<?xml version="1.0" encoding="UTF-8"?>
<ref id="R93">
 <label>93.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lampson</surname>
    <given-names>BL</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>HT</given-names>
   </name>
   <name>
    <surname>Davids</surname>
    <given-names>MS</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia</article-title>. 
  <source>
   <italic toggle="yes">Blood Adv.</italic>
  </source>
  <year>2019</year>;
  <volume>3</volume>:
  <fpage>1167</fpage>â€“
  <lpage>1174</lpage>.
  <pub-id pub-id-type="pmid">30967392</pub-id>
 </mixed-citation>
</ref>
